| 1 |
Carey EJ, Lai JC, Sonnenday C, et al. A North American expert opinion statement on sarcopenia in liver transplantation[J]. Hepatology, 2019, 70(5): 1816-1829.
|
| 2 |
van Vugt JLA, Levolger S, de Bruin RWF, et al. Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation[J]. Am J Transplant, 2016, 16(8): 2277-2292.
|
| 3 |
Dhaliwal A, Williams FR, El-Sherif O, et al. Sarcopenia in liver transplantation: an update[J]. Curr Hepatol Rep, 2020, 19(2): 128-137.
|
| 4 |
Duarte-Rojo A, Bloomer PM, Rogers RJ, et al. Introducing EL-FIT (exercise and liver fitness): a smartphone app to prehabilitate and monitor liver transplant candidates[J]. Liver Transpl, 2021, 27(4): 502-512.
|
| 5 |
Kim SH, Kim KA, Chu SH, et al. Self-management using eHealth technologies for liver transplant recipients: scoping review[J]. J Med Internet Res, 2024, 26: e56664.
|
| 6 |
鲁雪梅,杨宇航,王恺悌,等. 肌少症在肝移植领域的研究进展[J]. 中华消化外科杂志,2025, 24(11): 1501-1506.
|
| 7 |
Kumar A, Davuluri G, Silva RNE, et al. Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis[J]. Hepatology, 2017, 65(6): 2045-2058.
|
| 8 |
Chae MS, Moon KU, Jung JY, et al. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation[J]. Liver Transpl, 2018, 24(5): 623-633.
|
| 9 |
Jeon JY, Wang HJ, Ock SY, et al. Newly developed sarcopenia as a prognostic factor for survival in patients who underwent liver transplantation[J]. PLoS One, 2015, 10(11): e0143966.
|
| 10 |
Schakman O, Kalista S, Barbé C, et al. Glucocorticoid-induced skeletal muscle atrophy[J]. Int J Biochem Cell Biol, 2013, 45(10): 2163-2172.
|
| 11 |
Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis[J]. Am J Transplant, 2004, 4(4): 583-595.
|
| 12 |
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(1): 16-31.
|
| 13 |
Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307.e2.
|
| 14 |
Cho MR, Lee S, Song SK. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction[J]. J Korean Med Sci, 2022, 37(18): e146.
|
| 15 |
中华医学会器官移植学分会肝移植学组,中国医师协会器官移植医师分会. 中国肝移植受者肌肉减少症临床诊疗指南[J/OL]. 中华移植杂志:电子版,2024, 18(6): 355-365.
|
| 16 |
Rubbieri G, Mossello E, Di Bari M. Techniques for the diagnosis of sarcopenia[J]. Clin Cases Miner Bone Metab, 2014, 11(3): 181-184.
|
| 17 |
Guttikonda D, Smith AL. Sarcopenia assessment techniques[J]. Clin Liver Dis (Hoboken), 2021, 18(4): 189-192.
|
| 18 |
Albano D, Messina C, Vitale J, et al. Imaging of sarcopenia: old evidence and new insights[J]. Eur Radiol, 2020, 30(4): 2199-2208.
|
| 19 |
Chianca V, Albano D, Messina C, et al. Sarcopenia: imaging assessment and clinical application[J]. Abdom Radiol (NY), 2022, 47(9): 3205-3216.
|
| 20 |
Lee K, Shin Y, Huh J, et al. Recent issues on body composition imaging for sarcopenia evaluation[J]. Korean J Radiol, 2019, 20(2): 205-217.
|
| 21 |
Fu H, Wang L, Zhang W, et al. Diagnostic test accuracy of ultrasound for sarcopenia diagnosis: a systematic review and meta-analysis[J]. J Cachexia Sarcopenia Muscle, 2023, 14(1): 57-70.
|
| 22 |
Nijholt W, Scafoglieri A, Jager-Wittenaar H, et al. The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review[J]. J Cachexia Sarcopenia Muscle, 2017, 8(5): 702-712.
|
| 23 |
Dunn MA, Rogal SS, Duarte-Rojo A, et al. Physical function, physical activity, and quality of life after liver transplantation[J]. Liver Transpl, 2020, 26(5): 702-708.
|
| 24 |
Dunn MA, Kappus MR, Bloomer PM, et al. Wearables, physical activity, and exercise testing in liver disease[J]. Semin Liver Dis, 2021, 41(2): 128-135.
|
| 25 |
Kim Y. Emerging treatment options for sarcopenia in chronic liver disease[J]. Life (Basel), 2021, 11(3): 250.
|
| 26 |
Montgomery J, Englesbe M. Sarcopenia in liver transplantation[J]. Curr Transplant Rep, 2019, 6(1): 7-15.
|
| 27 |
Okubo T, Atsukawa M, Tsubota A, et al. Effect of vitamin D supplementation on skeletal muscle volume and strength in patients with decompensated liver cirrhosis undergoing branched chain amino acids supplementation: a prospective, randomized, controlled pilot trial[J]. Nutrients, 2021, 13(6): 1874.
|
| 28 |
Williams FR, Vallance A, Faulkner T, et al. Home-based exercise in patients awaiting liver transplantation: a feasibility study[J]. Liver Transpl, 2019, 25(7): 995-1006.
|
| 29 |
Benmassaoud A, Martel M, Carli F, et al. Prehabilitation in patients awaiting liver transplantation[J]. Transplant Rev (Orlando), 2024, 38(2): 100835.
|
| 30 |
Duarte-Rojo A, Bloomer PM, Grubbs RK, et al. Use of a mobile-assisted telehealth regimen to increase exercise in transplant candidates: a home-based prehabilitation pilot and feasibility trial[J]. Clin Transl Gastroenterol, 2023, 14(11): e00601.
|
| 31 |
Sinclair M, Grossmann M, Angus PW, et al. Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease[J]. J Gastroenterol Hepatol, 2016, 31(3): 661-667.
|
| 32 |
Bruno BJ, Weavil JC, Ogle J, et al. Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: a randomized, placebo-controlled phase 2 trial[J]. Hepatology, 2025, 81(6): 1764-1775.
|
| 33 |
Sinclair M, Grossmann M, Hoermann R, et al. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial[J]. J Hepatol, 2016, 65(5): 906-913.
|
| 34 |
Han HQ, Zhou X, Mitch WE, et al. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential[J]. Int J Biochem Cell Biol, 2013, 45(10): 2333-2347.
|
| 35 |
Chen W, Yao J, Wang H, et al. Effects of digital health interventions on muscle mass, muscle strength, and physical function in older adults with sarcopenia: a systematic review and meta-analysis[J]. Front Public Health, 2025, 13: 1711514.
|
| 36 |
He S, Meng D, Wei M, et al. Proposal and validation of a new approach in tele-rehabilitation with 3D human posture estimation: a randomized controlled trial in older individuals with sarcopenia[J]. BMC Geriatr, 2024, 24(1): 586.
|
| 37 |
Hong J, Kim J, Kim SW, et al. Effects of home-based tele-exercise on sarcopenia among community-dwelling elderly adults: body composition and functional fitness[J]. Exp Gerontol, 2017, 87(Pt A): 33-39.
|
| 38 |
Tuan SH, Chang LH, Sun SF, et al. Assessing the clinical effectiveness of an exergame-based exercise training program using ring fit adventure to prevent and postpone frailty and sarcopenia among older adults in rural long-term care facilities: randomized controlled Trial[J]. J Med Internet Res, 2024, 26:e59468.
|
| 39 |
Tian M, Wang B, Xue Z, et al. Telemedicine for follow-up management of patients after liver transplantation: cohort study[J]. JMIR Med Inform, 2021, 9(5): e27175.
|
| 40 |
Lim WS, Cheong CY, Lim JP, et al. Singapore clinical practice guidelines for sarcopenia: screening, diagnosis, management and prevention[J]. J Frailty Aging, 2022, 11(4): 348-369.
|
| 41 |
Veras M, Auger LP, Sigouin J, et al. Ethics and equity challenges in telerehabilitation for older adults: rapid review[J]. JMIR Aging, 2025, 8: e69660.
|